Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas. Cancer. 2005 Apr 01; 103(7):1431-8.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Bone Neoplasms
Boronic Acids
Bortezomib
Drug Administration Schedule
Fatigue
Female
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Nervous System Diseases
Proteasome Inhibitors
Pyrazines
Sarcoma
Soft Tissue Neoplasms
Treatment Outcome
authors with profiles
Andrew S Kraft